Clinical Trials Browser

Neoplasm Metastasis × VS-5584 × Clear all

NCT01991938 2017-01-27

Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma

Phase 1 Terminated

Lymphoma, Neoplasm Metastasis